EXOGENOUS BUT NOT ENDOGENOUS EBV INDUCES LYMPHOMAS IN BEIGE NUDE XID MICE CARRYING HUMAN LYMPHOID XENOGRAFTS

被引:10
作者
DOSCH, HM [1 ]
COCHRANE, DMG
COOK, VA
LEEDER, JS
CHEUNG, RK
机构
[1] UNIV TORONTO, HOSP SICK CHILDREN,RES INST,DEPT PEDIAT, 555 UNIV AVE, TORONTO M5G 1X8, ONTARIO, CANADA
[2] UNIV TORONTO, HOSP SICK CHILDREN, RES INST, DEPT IMMUNOL, TORONTO M5G 1X8, ONTARIO, CANADA
关键词
EBV; LYMPHOMA; HUMAN XENOGRAFTS; IMMUNODEFICIENCY;
D O I
10.1093/intimm/3.7.731
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Epstein-Barr virus (EBV) is a latent human herpes virus that growth-transforms EBV receptor/CD21+ B cells and is associated with several high-frequency malignancies. Reactivation of latent EBV occurs in approximately 1/3 of organ graph recipients and a majority of AIDS patients; EBV-positive B lymphoproliferative lesions represent often fatal complications in organ transplantation and late-stage AIDS. Although such lymphomas can arise from endogenous virus, the high tumor risk in EBV-seronegative transplant recipients implies de novo infection, in particular virus transmission with intra-graft B lymphocytes. Since SCID mice engrafted with human lymphocytes (SCID(hum)) typically develop endogenous EBV+ (human) tumors in their graft it is difficult to study exogenous virus transmission in this model. We here demonstrate that beige/nude/xid mice engrafted with human lymphoid cells (BNX(hum)) selectively accept human B but not T cell grafts. Unexpectedly these mice fail to develop endogenous lymphomas observed in SCID(hum) mice engrafted in parallel. However, injection of as few as < 500 EBV particles produces rapidly fatal, polyclonal lymphomas in BNX(hum) animals. This virus sensitivity of BNX(hum) approaches conditions for EBV transmission with organ grafts.
引用
收藏
页码:731 / 735
页数:5
相关论文
共 32 条
[1]   DNA-SEQUENCE AND EXPRESSION OF THE B95-8 EPSTEIN-BARR VIRUS GENOME [J].
BAER, R ;
BANKIER, AT ;
BIGGIN, MD ;
DEININGER, PL ;
FARRELL, PJ ;
GIBSON, TJ ;
HATFULL, G ;
HUDSON, GS ;
SATCHWELL, SC ;
SEGUIN, C ;
TUFFNELL, PS ;
BARRELL, BG .
NATURE, 1984, 310 (5974) :207-211
[2]  
BRUSAMOLINO E, 1989, HAEMATOLOGICA, V74, P605
[3]   EPSTEIN-BARR-VIRUS INDUCES AGGRESSIVE LYMPHOPROLIFERATIVE DISORDERS OF HUMAN B-CELL ORIGIN IN SCID/HU CHIMERIC MICE [J].
CANNON, MJ ;
PISA, P ;
FOX, RI ;
COOPER, NR .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (04) :1333-1337
[4]  
CLEARY ML, 1988, BLOOD, V72, P349
[5]  
DAVEY DD, 1989, MODERN PATHOL, V2, P27
[6]  
DOSCH HM, 1989, J IMMUNOL, V143, P2464
[7]  
DOSCH HM, 1985, J IMMUNOL, V134, P336
[8]   EBV UTILIZES A UNIQUE ACTIVATION PATHWAY FOR THE TRANSFORMATION OF HUMAN B-CELLS [J].
DOSCH, HM ;
LAM, P ;
HUI, MF ;
HIBI, T ;
CHEUNG, RK .
INTERNATIONAL IMMUNOLOGY, 1990, 2 (09) :833-848
[9]   EPSTEIN-BARR-VIRUS-RELATED MALIGNANT B-CELL LYMPHOPLASMACYTIC LYMPHOMA FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR APLASTIC-ANEMIA [J].
FORMAN, SJ ;
SULLIVAN, JL ;
WRIGHT, C ;
RATECH, H ;
RACKLIN, B ;
BLUME, KG .
TRANSPLANTATION, 1987, 44 (02) :244-249
[10]  
FULOP GM, 1989, J EXP MED, V170, P1427